BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 11345037)

  • 1. Effects of Ukrain on the activities of DNA-nicking enzymes.
    Votrin II; Voltchek IV; Kurochkin SN; Kolobkov SL
    Drugs Exp Clin Res; 2000; 26(5-6):267-73. PubMed ID: 11345037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of apoptosis in cultured Chinese hamster ovary cells by Ukrain and its synergistic action with etoposide.
    Kurochkin SN; Kolobkov SL; Votrin II; Voltchek IV
    Drugs Exp Clin Res; 2000; 26(5-6):275-8. PubMed ID: 11345038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiomodification effects of Ukrain, a cytostatic and immunomodulating drug, on intracellular glucocorticoid reception during short-term gamma-irradiation.
    Luksa-Lichtenthaeler GL; Ladutko EI; Nowicky JW
    Drugs Exp Clin Res; 2000; 26(5-6):311-5. PubMed ID: 11345044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of Ukrain on the nuclear thyroid hormone receptors after short-term gamma-irradiation.
    Luksa-Lichtenthaler GL; Ladutko EI; Nowicky JW
    Drugs Exp Clin Res; 2000; 26(5-6):307-10. PubMed ID: 11345043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ukrain: a novel antitumor drug.
    Uglyanitsa KN; Nefyodov LI; Doroshenko YM; Nowicky JW; Volchek IV; Brzosko WJ; Hodysh YJ
    Drugs Exp Clin Res; 2000; 26(5-6):341-56. PubMed ID: 11345050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Ukrain on human liver alcohol dehydrogenase activity in vitro.
    Jagiełło-Wójtowicz E; Dudka J; Dawidek-Pietryka K
    Drugs Exp Clin Res; 2000; 26(5-6):337-9. PubMed ID: 11345049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ukrain (NSC-631570) influences on bone status: a review.
    Jabłoński M
    Drugs Exp Clin Res; 2000; 26(5-6):317-20. PubMed ID: 11345045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chitotriosidase as a new marker of macrophage stimulation in a tumor model treated with cyclophosphamide and Ukrain.
    Korolenko TA; Djanayeva SJ; Falameyeva OV; Wevers RA; Filjushina EE; Buzueva II; Kaledin VI; Sandula J; Nowicky J
    Drugs Exp Clin Res; 2000; 26(5-6):279-83. PubMed ID: 11345039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies concerning the effect of Ukrain in vivo and in vitro.
    Brüller W
    Drugs Exp Clin Res; 1992; 18 Suppl():13-6. PubMed ID: 1305037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of Ukrain on the redox processes of hepatocytes.
    Zhalilo LI; Susak YM; Zemskov SV; Susak IA
    Drugs Exp Clin Res; 1996; 22(3-5):189-91. PubMed ID: 8899328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative evaluation of the influence of the complex drug Ukrain and its components on the effects of radiation.
    Boyko VN; Zholus RB
    Drugs Exp Clin Res; 1998; 24(5-6):331-3. PubMed ID: 10190098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intermittent three-month treatment with Ukrain in intact and ovariectomized rats. Part II: Effect on bone mineral density of the femur.
    Jabłoński M; Gorzelak M; Patyra M; Jagiełło-Wójtowicz E
    Drugs Exp Clin Res; 2000; 26(5-6):327-31. PubMed ID: 11345047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of Ukrain and cyclophosphamide administration on HA-1 murine hepatoma and LS lymphoma on aspartic proteinase cathepsin D.
    Djanayeva SJ; Korolenko TA; Svechnikova IG; Falameyeva OV; Korolenko E; Kaledin VI; Nowicky J
    Drugs Exp Clin Res; 2000; 26(5-6):293-9. PubMed ID: 11345041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative evaluation of blood plasma and tumor tissue amino acid pool in radiation or neoadjuvant preoperative therapies of breast cancer with the antitumor drug Ukrain.
    Nefyodov LI; Uglyanitsa KN; Smirnov VY; Karavay AV; Brzosko W
    Drugs Exp Clin Res; 2000; 26(5-6):231-7. PubMed ID: 11345030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proapoptotic activity of Ukrain is based on Chelidonium majus L. alkaloids and mediated via a mitochondrial death pathway.
    Habermehl D; Kammerer B; Handrick R; Eldh T; Gruber C; Cordes N; Daniel PT; Plasswilm L; Bamberg M; Belka C; Jendrossek V
    BMC Cancer; 2006 Jan; 6():14. PubMed ID: 16417634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intermittent three-month treatment with Ukrain in intact and ovariectomized rats. Part I: Effect on selected biomechanical parameters of the femur.
    Jabłoński M; Gorzelak M; Patyra M; Jagiełło-Wójtowicz E
    Drugs Exp Clin Res; 2000; 26(5-6):321-5. PubMed ID: 11345046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intermittent three-month treatment with Ukrain in intact and ovariectomized rats. Part III: Effect on the native electron paramagnetic resonance signal intensity of the femur.
    Jabłoński M; Korczak W; Gorzelak M; Jagiełło-Wójtowicz E
    Drugs Exp Clin Res; 2000; 26(5-6):333-6. PubMed ID: 11345048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Results of Ukrain monotherapy of prostate cancer.
    Uglyanitsa KN; Nechiporenko NA; Nefyodov LI; Doroshenko YM; Brzosko W; Nowicky W
    Drugs Exp Clin Res; 2000; 26(5-6):191-3. PubMed ID: 11345026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cysteine proteinase inhibitor level in tumor and normal tissues in control and cured mice.
    Poteryaeva ON; Falameyeva OV; Korolenko TA; Kaledin VI; Djanayeva SJ; Nowicky JW; Sandula J
    Drugs Exp Clin Res; 2000; 26(5-6):301-6. PubMed ID: 11345042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective inhibition of in vitro cell growth by the anti-tumour drug Ukrain.
    Hohenwarter O; Strutzenberger K; Katinger H; Liepins A; Nowicky JW
    Drugs Exp Clin Res; 1992; 18 Suppl():1-4. PubMed ID: 1305034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.